PTPN22 and type 1 diabetes mellitus: The major findings of the present study indicate the ability of LiposiRNA-Sig10L lipoplexes (at 80 pmols of siRNA) to specifically target and significantly decrease C1858T PTPN22 mRNA levels in heterozygous T1D PBMC.